Skip to main content
SpringerLink
Log in

HBV/HCV testing in ED setting highly cost effective in the UK

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The study was funded in part by Gilead.

Reference

  • Williams J, et al. An Economic Evaluation of the Cost-Effectiveness of Opt-Out Hepatitis B and Hepatitis C Testing in an Emergency Department Setting in the United Kingdom. Value in Health : 14 Jul 2020. Available from: URL: https://doi.org/10.1016/j.jval.2020.03.014

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

HBV/HCV testing in ED setting highly cost effective in the UK. PharmacoEcon Outcomes News 858, 16 (2020). https://doi.org/10.1007/s40274-020-6989-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6989-9

Search

Navigation